Viewing Study NCT06199466


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-28 @ 2:01 PM
Study NCT ID: NCT06199466
Status: TERMINATED
Last Update Posted: 2025-12-08
First Post: 2023-12-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module